Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma

Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma

Show other versions (1)

Background/Aims Daratumumab has shown an encouraging antitumor effect in patients with multiple myeloma (MM), and was known to alter the immune properties by off-targeting immunosuppressive cells. Here, we aimed to evaluate the change in absolute lymphocyte count (ALC) as a surrogate marker for pred...

Full description

Bibliographic Details
Main Authors: Hee Jeong Cho, Jae-Cheol Jo, Yoo Jin Lee, Myung Won Lee, Do Young Kim, Ho Jin Shin, Sung Nam Im, Ji Hyun Lee, Sung Hwa Bae, Young Rok Do, Won Sik Lee, Min Kyung Kim, Jina Jung, Jung Min Lee, Ju-Hyung Kim, Dong Won Baek, Sang-Kyun Sohn, Joon Ho Moon
Format: Article
Language:English
Published: The Korean Association of Internal Medicine 2023-03-01
Series:The Korean Journal of Internal Medicine
Subjects:
multiple myeloma
daratumumab
lymphocyte count
biomarkers
survival analysis
Online Access:http://www.kjim.org/upload/kjim-2022-183.pdf

Internet

http://www.kjim.org/upload/kjim-2022-183.pdf

Similar Items